Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Because asthma affects so many people worldwide, the asthma products industry is driven. As asthma rates climb worldwide, more individuals prefer simple asthma treatments. This impacts market growth.
The asthma product industry is driven by rapid breathing device technology advancements. Innovative products like smart inhalers, nebulizers with improved delivery methods, and user-friendly designs are transforming the industry.
Programs that educate consumers and healthcare staff about asthma impact the market. People are learning how vital it is to use devices appropriately, follow treatment programs, and recognize symptoms early, which boosts asthma device sales.
Air pollution and allergens increase asthma prevalence. As pollution rises, more individuals use breathing devices to manage their symptoms and feel better.
Number of asthmatic kids is a market element. Kids' asthma problems fuel the demand for age-appropriate inhalers and nebulizers, changing the market.
Government lung health initiatives and legislation impact the asthma product industry. Supportive legislation, financing, and public health activities make breathing equipment more inexpensive and accessible, changing market patterns.
The market is impacted by patient demand for small, easy-to-use devices. Small, portable, and easy-to-use inhalers and nebulizers are preferred by asthmatics. This affects asthma gadget development and popularity.
Biologics and specialized therapy impact asthma products. Targeted medications and biologics for particular asthma types vary the devices required for therapy.
The market depends on the healthcare system and treatment facility accessibility. Different healthcare access levels affect asthma product market trends. This is because certain locations lack amenities.
Research & development and new breathing products modify the market. Businesses get a competitive advantage by investing in innovative, valuable goods, which grows the market.
People with COPD or allergic rhinitis impact the asthma product industry. various common respiratory illnesses may need various devices for treatment.
Patients' treatment compliance and behavior impact the market. Easier-to-use devices with clear instructions and features that promote treatment compliance improve asthma management and boost demand.
Asthma Devices Market Highlights:
Asthma Devices Market Scenario:
The Asthma Devices Market is projected to reach USD 7202.6 Million by 2030 at 4.7% CAGR during the forecast period 2022-2030.Asthma is a chronic inflammatory lung disease that narrows the airways. Asthma causes recurring periods of wheezing, chest tightness, shortness of breath, and coughing. Mostly, the symptoms associated with asthma are short-lived and can be easily treated. Asthma inhalers are medical devices which deliver medication into the body via the lungs, thereby, treating asthma and chronic obstructive pulmonary disease. Increasing prevalence of asthma is one of the major drivers for the market growth. According to the World Health Organization in 2017, approximately 235 million people suffered from asthma. Moreover, it was estimated that in 2015, the disease killed approximately 383 million patients around the globe. Additionally, rising healthcare expenditures and increasing awareness fuel the market growth. However, long treatment procedures and low per capita income followed by lack of favorable reimbursement policies in the developing countries will restrain the market growth during the forecast period.Â
Figure 1:- Global asthma devices market share, by region 
Â
Sources: WHO, annual reports, press release, white paper, and company presentation
Asthma Devices Market Segmentation
The global asthma devices market is segmented on the basis of type, technology, and end users.
On the basis of the type, the market is segmented into inhalers, nebulizers, and others. The inhalers segment is sub-segmented into metered-dose inhalers and dry powder inhalers. The metered-dose inhalers segment, by inhalers, is further categorized into standard pressurized metered-dose inhalers, breath-activated pressurized metered-dose inhalers, metered-dose inhalers with a spacer, and others. The nebulizers segment is sub-segmented into compressor nebulizers, ultrasonic nebulizers, mesh nebulizers, and others.
On the basis of technology, the asthma devices market is segmented into manually operated inhaler devices, digitally operated inhaler devices, and others.
On the basis of end users, the market is segmented into hospital, clinics, retail pharmacies, and others.
Asthma Devices Market Regional AnalysisÂ
The Americas dominate the global asthma devices market owing to a well-developed healthcare sector and huge patient population for asthma diseases. According to the Centres for Disease Control and Prevention, in 2015, approximately, 7.8% of the total population in the U.S. was identified for the presence of asthma. Moreover, changing lifestyle and increasing healthcare expenditure fuels the market growth. Additionally, the presence of global players like Merck & Co., Inc. and Baxter, and others boost market growth during the forecast period.Â
Europe is the second largest asthma devices market owing to a well-developed healthcare infrastructure and huge patient population. Moreover, government support for research & development and rising healthcare expenditures fuel the market growth. According to a study published in the Asthma Research and Practice journal in 2017, the yearly estimated cost for all the asthmatics per patient is about USD 1,900. Additionally, the presence of the developed economies like the U.K, Germany, and France within the region boosts the market growth.Â
Asia Pacific is the fastest growing region in the global market due to the presence of a huge patient population and continuously developing economies like India and China. According to a study of the Indian Chest Society in 2015, 300 million people suffered from asthma worldwide and about a tenth of its share is in India. Moreover, as per the Indian Brand Equity Foundation in 2017, the Indian healthcare sector is one of the fastest growing industries and is expected to advance at a CAGR of 22.8% and reach USD 280 billion by 2020. Moreover, favorable government policies like reduced excise and customs duty followed by the exemptions in service tax along boosts the market growth.Â
On the other hand, the Middle East & Africa holds the least share of the global asthma devices market due to the presence of poor economy, especially within the African region. The absence of the developed healthcare sector and stringent government policies restrain the market growth within the African region. Majority of the market within the region is held by the Middle East due to huge healthcare expenditures.Â
Key players for Asthma Devices Market
GlaxoSmithKline plc. (Europe), Merck & Co., Inc. (U.S.), 3M (U.S.), Aristopharma Ltd. (Asia Pacific), SRS PHARMACEUTICALS PVT. LTD. (Asia Pacific), AstraZeneca (Europe), Baxter. (U.S.), Boehringer Ingelheim GmbH (Europe), Koninklijke Philips N.V. (Europe), and others.
Intended Audience
- Pharmaceutical Companies
- Biotechnological Institutes
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Market Research and Consulting Service ProvidersÂ
Research Methodology
Â
Sources: WHO, annual reports, press release, white paper, and company presentationÂ
Â
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
